Drug Enforcement Administration March 2015 – Federal Register Recent Federal Regulation Documents

Importer of Controlled Substances Application: Meda Pharmaceuticals, Inc.
Document Number: 2015-06971
Type: Notice
Date: 2015-03-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: HOSPIRA
Document Number: 2015-06969
Type: Notice
Date: 2015-03-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
Document Number: 2015-06967
Type: Notice
Date: 2015-03-27
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Apertus Pharmaceuticals
Document Number: 2015-06966
Type: Notice
Date: 2015-03-27
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Penick Corporation
Document Number: 2015-06734
Type: Notice
Date: 2015-03-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc.
Document Number: 2015-06733
Type: Notice
Date: 2015-03-24
Agency: Drug Enforcement Administration, Department of Justice
Substances Temporarily Controlled Under Schedule I of the Controlled Substances Act
Document Number: 2015-06460
Type: Rule
Date: 2015-03-20
Agency: Drug Enforcement Administration, Department of Justice
This final rule makes technical and conforming amendments to the Drug Enforcement Administration regulations listing substances temporarily controlled under schedule I of the Controlled Substances Act. This final rule eliminates references to 7 substances that were previously subject to temporary control, but which have since been permanently controlled under schedule I, and redesignates 23 other substances that are currently temporarily controlled under schedule I. This action makes no substantive changes to the affected regulation.
Controlled Substances: 2015 Proposed Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids
Document Number: 2015-06456
Type: Notice
Date: 2015-03-20
Agency: Drug Enforcement Administration, Department of Justice
Three synthetic cannabinoids: N-(1-amino-3-methyl-1-oxobutan- 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N- (1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-car boxamide (AB-PINACA), and [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone (THJ-2201) were temporarily placed in schedule I of the Controlled Substances Act by a final order published by the Drug Enforcement Administration on January 30, 2015 (80 FR 5042). This means that any person that wishes to manufacture AB-CHMINACA, AB-PINACA, or THJ-2201 after January 30, 2015, must be registered with the Drug Enforcement Administration and have obtained a manufacturing quota pursuant to 21 CFR part 1303. The Drug Enforcement Administration cannot issue individual manufacturing quotas for AB-CHMINACA, AB-PINACA, or THJ-2201 until it establishes aggregate production quotas. Therefore, this notice proposes the 2015 aggregate production quotas for AB-CHMINACA, AB- PINACA, and THJ-2201.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.